Omega Healthcare Investors, Inc.
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.19B | $1.05B | $949.7M | $878.2M | $1.06B | $892.4M | $928.8M | $881.7M |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — | — | — |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | $104.1M | $88.0M | $81.5M | $69.4M | $64.6M | $59.9M | $57.9M | $63.5M |
| Operating Income | $839.3M | $650.4M | $490.6M | $669.4M | $650.7M | $385.7M | $551.7M | $497.6M |
| Operating Margin | 70.5% | 61.9% | 51.7% | 76.2% | 61.2% | 43.2% | 59.4% | 56.4% |
| Interest Expense | $215.0M | $221.7M | $235.5M | $233.2M | $234.6M | $223.4M | $208.7M | $192.5M |
| Pretax Income | $624.2M | $428.7M | $255.1M | $436.1M | $416.1M | $162.3M | $343.8M | $296.5M |
| Income Tax Expense | $14.7M | $10.9M | $6.3M | $4.6M | $3.8M | $4.9M | $2.8M | $3.0M |
| Net Income | $590.2M | $406.3M | $242.2M | $438.8M | $428.3M | $163.5M | $351.9M | $293.9M |
| Net Margin | 49.6% | 38.6% | 25.5% | 50.0% | 40.3% | 18.3% | 37.9% | 33.3% |
| EPS (Basic) | $1.96 | $1.57 | $1.01 | $1.81 | $1.76 | $0.70 | $1.60 | $1.41 |
| EPS (Diluted) | $1.94 | $1.55 | $1.00 | $1.80 | $1.75 | $0.70 | $1.58 | $1.40 |
| Shares Outstanding (Basic) | 291.6M | 258.1M | 240.5M | 236.3M | 236.9M | 227.7M | 213.4M | 200.3M |
| Shares Outstanding (Diluted) | 305.0M | 270.5M | 250.5M | 244.3M | 244.3M | 235.1M | 222.1M | 209.7M |
| Dividends Per Share | $2.68 | $2.68 | $2.68 | $2.68 | $2.68 | $2.68 | $2.65 | $2.64 |